Literature DB >> 16835346

Familial risks for cervical tumors in full and half siblings: etiologic apportioning.

Kari Hemminki1, Bowang Chen.   

Abstract

Many studies have shown familial aggregation for cervical cancer, but they have been unable to distinguish between shared environmental and genetic effects. Full and half-siblings were identified from the nationwide Swedish Family-Cancer Database, including invasive and in situ cervical cancers in women up to age 70 years. Half-siblings were defined through a common father or mother. Standardized incidence ratios, adjusted for several variables, were calculated for proband-wise risks between full and half-siblings. The familial risk for full siblings was 1.84, compared with 1.40 for maternal and 1.27 for paternal half-siblings. These data were used to apportion familial risk for cervical tumors in full siblings into a heritable component, accounting for 64%, and an environmental component, accounting for 36% of the total risk. No evidence for gene-environment interactions was found. The intractable difficulty in separating cervical cancer causation will be an obstacle for a successful identification of susceptibility genes.

Entities:  

Mesh:

Year:  2006        PMID: 16835346     DOI: 10.1158/1055-9965.EPI-05-0933

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  16 in total

1.  Cervix smear abnormalities: linking pathology data in female twins, their mothers and sisters.

Authors:  Jacqueline M Vink; Folkert J van Kemenade; Chris J L M Meijer; Mariel K Casparie; Gerrit A Meijer; Dorret I Boomsma
Journal:  Eur J Hum Genet       Date:  2010-08-18       Impact factor: 4.246

2.  Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma.

Authors:  Teresa Warchoł; Lukasz Kruszyna; Margarita Lianeri; Andrzej Roszak; Paweł P Jagodziński
Journal:  Pathol Oncol Res       Date:  2010-08-03       Impact factor: 3.201

3.  Contribution of IL12A and IL12B polymorphisms to the risk of cervical cancer.

Authors:  Andrzej Roszak; Adrianna Mostowska; Anna Sowińska; Margarita Lianeri; Pawel P Jagodziński
Journal:  Pathol Oncol Res       Date:  2012-05-22       Impact factor: 3.201

4.  Cancer risk in first- and second-degree relatives of men with poor semen quality.

Authors:  Ross E Anderson; Heidi A Hanson; Darshan P Patel; Erica Johnstone; Kenneth I Aston; Douglas T Carrell; William T Lowrance; Ken R Smith; James M Hotaling
Journal:  Fertil Steril       Date:  2016-06-20       Impact factor: 7.329

Review 5.  Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes.

Authors:  Shing Cheng Tan; Ravindran Ankathil
Journal:  Tumour Biol       Date:  2015-08-05

6.  The role of family history of cancer on cervical cancer screening behavior in a population-based survey of women in the Southeastern United States.

Authors:  Jessica D Bellinger; Heather M Brandt; James W Hardin; Shalanda A Bynum; Patricia A Sharpe; Dawnyéa Jackson
Journal:  Womens Health Issues       Date:  2013-05-27

Review 7.  Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers.

Authors:  Simon R Best; Kevin J Niparko; Sara I Pai
Journal:  Otolaryngol Clin North Am       Date:  2012-08       Impact factor: 3.346

8.  Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.

Authors:  Mahboobeh Safaeian; Allan Hildesheim; Paula Gonzalez; Kai Yu; Carolina Porras; Qizhai Li; Ana Cecilia Rodriguez; Mark E Sherman; Mark Schiffman; Sholom Wacholder; Robert Burk; Rolando Herrero; Laurie Burdette; Stephen J Chanock; Sophia S Wang
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

9.  Involvement of Toll-like Receptor 9 polymorphism in cervical cancer development.

Authors:  Andrzej Roszak; Margarita Lianeri; Anna Sowińska; Pawel P Jagodziński
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

10.  MDM2 polymorphism associated with the development of cervical lesions in women infected with Human papillomavirus and using of oral contraceptives.

Authors:  Carolina Mm Amaral; Katerina Cetkovská; Ana Pad Gurgel; Marcus V Cardoso; Bárbara S Chagas; Sérgio Sl Paiva Júnior; Rita de Cássia Pereira de Lima; Jacinto C Silva-Neto; Luiz Af Silva; Maria Tc Muniz; Valdir Q Balbino; Antonio C Freitas
Journal:  Infect Agent Cancer       Date:  2014-07-18       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.